Anzeige
Meldung des Tages: Analyst sieht bei dieser Food-Tech-Aktie jetzt rund 100 % Kurspotenzial

Insmed Aktie News

Aktie
WKN:  A1JJA3 ISIN:  US4576693075 US-Symbol:  INSM Branche:  Biotechnologie Land:  USA
156,21 $
-4,18 $
-2,61%
132,06 € 23.01.26
Depot/Watchlist
Marktkapitalisierung *
27,47 Mrd. €
Streubesitz
-
KGV
-28,49
neu: Nachhaltigkeits-Score
45 %
Index-Zuordnung
Nasdaq 100

Insmed News

22.01.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM PR Newswire
15.01.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM PR Newswire
12.01.26 - ARIVA.DE Redaktion
Nasdaq 100 heute kaum bewegt – Western Digital mit größtem Kursgewinn (25.821 Pkt.)
Die Aktie von Western Digital ist zur Stunde der größte Gewinner im Nasdaq 100. Gegenwärtig liegt der Auswahlindex mit 0,21 Prozent ganz leicht im Plus.
09.01.26 - PR Newswire
Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference PR Newswire
08.01.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM PR Newswire
02.01.26 - PR Newswire
Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference
Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference PR Newswire
01.01.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM PR Newswire
17.12.25 - PR Newswire
Insmed Provides Clinical and Business Update
Insmed Provides Clinical and Business Update PR Newswire
04.12.25 - PR Newswire
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
18.11.25 - PR Newswire
European Commission Approves BRINSUPRI® (brensocatib) as the First and Only Treatment To Date Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union
European Commission Approves BRINSUPRI® (brensocatib) as the First and Only Treatment To Date Approved for Non-​Cystic Fibrosis Bronchiectasis in the European Union PR ...
18.11.25 - PR Newswire
European Commission Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union
European Commission Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment Approved for Non-​Cystic Fibrosis Bronchiectasis in the European Union PR Newswire
17.11.25 - wallstreetONLINE Redaktion
Nach Verkauf von Microsoft: Milliardär Stanley Druckenmiller investiert 95.967.000 Dollar in E-Commerce & KI
Der Milliardär Stanley Druckenmiller hat gerade seine Beteiligung an Microsoft abgestoßen und gleichzeitig Millionen Dollar in eine Wette auf E-​Commerce, KI und Robotik ...
13.11.25 - PR Newswire
Insmed Strengthens Communities Worldwide During Fourth Annual Global Day of Good
Insmed Strengthens Communities Worldwide During Fourth Annual Global Day of Good PR Newswire
05.11.25 - PR Newswire
Insmed To Present at November and December 2025 Investor Conferences
Insmed To Present at November and December 2025 Investor Conferences PR Newswire
30.10.25 - PR Newswire
Insmed Reports Third-Quarter 2025 Financial Results and Provides Business Update
Insmed Reports Third-​Quarter 2025 Financial Results and Provides Business Update PR Newswire
23.10.25 - PR Newswire
Insmed Ranks No. 1 on Science's 2025 Top Biopharma Employers List
Insmed Ranks No. 1 on Science's 2025 Top Biopharma Employers List PR Newswire
17.10.25 - PR Newswire
CHMP Recommends EU Approval of BRINSUPRI™ (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis
CHMP Recommends EU Approval of BRINSUPRI™ (brensocatib) for the Treatment of Non-​Cystic Fibrosis Bronchiectasis PR Newswire
16.10.25 - PR Newswire
Insmed to Present Multiple Analyses from Phase 3 ASPEN Study at the American College of Chest Physicians Annual Meeting 2025
Insmed to Present Multiple Analyses from Phase 3 ASPEN Study at the American College of Chest Physicians Annual Meeting 2025 PR Newswire
15.10.25 - PR Newswire
Insmed to Host Third-Quarter 2025 Financial Results Conference Call on Thursday, October 30, 2025
Insmed to Host Third-​Quarter 2025 Financial Results Conference Call on Thursday, October 30, 2025 PR Newswire
22.09.25 - PR Newswire
Insmed to Present Multiple Abstracts at the European Respiratory Society Congress 2025
Insmed to Present Multiple Abstracts at the European Respiratory Society Congress 2025 PR Newswire

Newssuche

Videos

newspaper
22.01.26 -5,56%
Trading Insights vom 22.01.26
Preisschock bei Erdgas! Was sind die Gründe, wie geht man damit um? Gold auf neuem Allzeithoch: wie ... Mehr »
Anzeige

Aktie im Fokus

GOLD-AUSBRUCH
GMV Minerals
0,187 €
+13,3%
GMV Minerals Chart
Von der PEA zum Milliarden-Potenzial
Mehr zur Aktie »